Aesthetic devices refer to the devices that are used in cosmetic procedures for beautification, correction and improvement of body contour which includes fillers, breast implants, facial implants and penile implants. Body contouring devices apply ultrasound, thermal, radio frequency and infrared energy to improve the shape or appearance of the abdomen, arms, legs, and buttocks. GlobalData uses proprietary data and analytics to provide a comprehensive report on the body contouring devices devices market, including market shares of different players within Australia. Buy the latest report here.
Smarter leaders trust GlobalData
In 2022, GlobalData’s Market Model methodology determined that the leading player in the body contouring devices market in Australia was Cynosure followed by Allergan Aesthetics, Candela Medical, Cutera, Lumenis Be, Classys, Lutronic, Solta Medical, Fotona, InMode, Cocoon Medical and Venus Concept.
A Body contouring device includes surgical and non-surgical techniques and devices to reduce fat or cellulite from target areas. Minimally invasive body contouring devices refer to devices that alter the shape of different parts of the body using minimally invasive surgical techniques. Non invasive body contouring devices refer to devices that alter the shape of different parts of the body with the help of non-surgical techniques.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the body contouring devices devices market within Australia was expected to be over $20m in 2022.
For the latest complete market share analysis of body contouring devices device market in Australia, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
